Generation of animal model of diabetes by disrupting the ADP-ribosyl cyclase (CD38) gene

通过破坏 ADP-核糖基环化酶 (CD38) 基因建立糖尿病动物模型

基本信息

  • 批准号:
    08557009
  • 负责人:
  • 金额:
    $ 11.78万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
  • 财政年份:
    1996
  • 资助国家:
    日本
  • 起止时间:
    1996 至 1998
  • 项目状态:
    已结题

项目摘要

1. We produced CD38 (+/-) mice by homologous recombination in ES cells and subsequent Cre-lox P recombination. By crosses between heterozygous mutants (+/-), homozygotes (-/-) were yielded in the F2 generation in a distribution following Mendelian rules ; hence CD38-/- mice seemed to survive fetal development normally.2.RT-PCR and Western blot analysis showed that there was no detectable CD38 mRNA and protein in pancreatic islets from CD38-/- mice, suggesting that the gene disruption resulted in a null mutation of CD38.3. As compared with CD38+/+ islet homogenates, the ADP-ribosyl cy clase, cADPR hydrolase and NAD+-glycohydrolase activities of CD38-/- islet homogenates were greatly reduced, indicating that CD38 is mainly responsible for the synthesis and hydrolysis of cADPR in pancreatic beta cells.4. By radioimmunoassay, the cADPR content in CD38+/+ islets was greatly increased by high glucose stimulation. Although some amounts of cADPR were detected in CD3 8-I- islets when incubated … More in low glucose, the cADPR content was not at all increased by high glucose stimulation.5. The glucose-stimulated [Ca2+]i rise in CD38-/- islets was much lower than that in CD38+/+ islets in the digital imaging of fura-2 fluorescence.6. Although there were no significant differences in insulin secretion between CD38+/+ and CD38-/- islets at 2.5 and 10 mM glucose, insulin secretion from CD38-/- islets at 20 and 30 mM glucose was more than 50% decreased compared with CD38+/+ islets.7. In glucose-tolerance test, At 30 and 60 min after glucose injection, CD38-/- mice had much higher glucose levels than CD38+/+ mice. In CD38-/- mice, serum insulin levels at 15 ruin after glucose injection were significantly lower than those of CD38+/+ mice.8. CD38-/- mice carrying the human CD38 transgene were generated. The human CD38 transgene ameliorated the glucose intolerance and the decreased insulin secretion.9. Overall results indicate that the CD38-/- mice are suitable animal model of noninsulin-dependent diabetes mellitus. In fact, we found CD38 missense mutation and autoantibodies against CD38 in noninsulin-dependent diabetic patients. Less
1.我们通过ES细胞中的同源重组和随后的Cre-lox P重组产生了CD 38(+/-)小鼠。通过杂合突变体(+/-)之间的杂交,在F2代中产生纯合子(-/-),其分布遵循孟德尔规则; RT-PCR和Western blot分析显示,CD 38-/-小鼠胰岛中未检测到CD 38 mRNA和蛋白,表明基因破坏导致CD 38.3的无效突变。与CD 38 +/+胰岛匀浆相比,CD 38-/-胰岛匀浆的ADP-核糖环化酶、cADPR水解酶和NAD+-糖水解酶活性均显著降低,表明CD 38主要负责胰腺β细胞中cADPR的合成和水解.放射免疫分析显示高糖刺激可显著增加CD 38 +/+胰岛cADPR含量。虽然在孵育的CD 3 8-I-胰岛中检测到一定量的cADPR, ...更多信息 在低糖条件下,高糖刺激对cADPR含量无明显影响.在fura-2荧光数字成像中,CD 38-/-胰岛中葡萄糖刺激的[Ca 2 +]i升高远低于CD 38 +/+胰岛.虽然在2.5和10 mM葡萄糖下CD 38 +/+和CD 38-/-胰岛之间的胰岛素分泌没有显著差异,但与CD 38 +/+胰岛相比,在20和30 mM葡萄糖下来自CD 38-/-胰岛的胰岛素分泌减少超过50%。在葡萄糖耐量试验中,注射葡萄糖后30和60 min,CD 38-/-小鼠的血糖水平明显高于CD 38 +/+小鼠。在CD 38-/-小鼠中,注射葡萄糖后15天的血清胰岛素水平显著低于CD 38 +/+小鼠.产生携带人⑶ 38转基因的⑶ 38-/-小鼠。人CD 38转基因改善了葡萄糖耐受不良和胰岛素分泌减少。总体结果表明,CD 38-/-小鼠是合适的非胰岛素依赖型糖尿病动物模型。事实上,我们在非胰岛素依赖型糖尿病患者中发现了CD 38错义突变和抗CD 38自身抗体。少

项目成果

期刊论文数量(103)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ichiro Kato: "CD38 disruption impairs glucose -induced increases in cyclic ADP-ribose, [Ca^<2->]i, and insulin secretion." Journal of Biological Chemistry. 274・4. 1869-1872 (1999)
Ichiro Kato:“CD38 破坏会损害葡萄糖诱导的循环 ADP-核糖、[Ca^<2->]i 和胰岛素分泌。”《生物化学杂志》274·4 (1999)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
阿部倫明: "新しいReg遺伝子(Reg IIIδ)の発見 : その構造決定とマウスRegファミリーの遺伝子地図の作製" 糖尿病. 42. in press (1999)
Michiaki Abe:“发现一个新的 Reg 基因(Reg IIIδ):确定其结构并创建小鼠 Reg 家族的遗传图谱”糖尿病,出版 42。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yagui, K.et al.: "A missense mutation in the CD38 gene, a novel factor for insulin secretion : association with Type II diabetes mellitus in Japanese subjects and evidence of abnormal function when expressed in vitro" Diabetologia. 41. 1024-1028 (1998)
Yagui, K.等人:“CD38 基因中的错义突变是胰岛素分泌的新因素:与日本受试者的 II 型糖尿病相关以及体外表达时功能异常的证据”Diabetologia。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
阿部倫明: "新しいReg遺伝子(Reg IIIδ)の発見: その構造決定とマウスRegファミリーの遺伝子地図の作製" 糖尿病. 42(in press). (1999)
Michiaki Abe:“发现一个新的 Reg 基因(Reg IIIδ):确定其结构并创建小鼠 Reg 家族的遗传图谱”糖尿病 42(出版中)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
高澤 伸: "糖尿病患者における抗REG I自己抗体の存在" 糖尿病. 42(in press). (1999)
Shin Takazawa:“糖尿病患者中存在抗 REG I 自身抗体”糖尿病 42(出版中)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KATO Ichiro其他文献

KATO Ichiro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KATO Ichiro', 18)}}的其他基金

中期倭鏡の多角的研究
对日本中世纪镜子的多方面研究
  • 批准号:
    19H00012
  • 财政年份:
    2019
  • 资助金额:
    $ 11.78万
  • 项目类别:
    Grant-in-Aid for Encouragement of Scientists
General Study on Differences in Own Works with the Scores in the Performances of a Composers/Pianists
作曲家/钢琴家演奏乐谱与自己作品差异的综合研究
  • 批准号:
    17K02288
  • 财政年份:
    2017
  • 资助金额:
    $ 11.78万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A Study on the Reception of Baroque Music by Chopin
肖邦巴洛克音乐接受研究
  • 批准号:
    26370106
  • 财政年份:
    2014
  • 资助金额:
    $ 11.78万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A Study of the Fine Tempo Fluctuation in the Bach Performance
巴赫演奏中精细节奏波动的研究
  • 批准号:
    22520148
  • 财政年份:
    2010
  • 资助金额:
    $ 11.78万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Basicresearch for visualization of functional neuronal tract by gene transfer into CNS neurons
通过基因转移到中枢神经系统神经元实现功能神经束可视化的基础研究
  • 批准号:
    17390396
  • 财政年份:
    2005
  • 资助金额:
    $ 11.78万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Establishment and analyses of mouse models of glycine-encephalopathy by conditional knockout of mouse H protein-gene.
通过条件性敲除小鼠H蛋白基因建立小鼠甘氨酸脑病模型并进行分析。
  • 批准号:
    14370052
  • 财政年份:
    2002
  • 资助金额:
    $ 11.78万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似海外基金

Second Messenger Nucleotides of Enterococcus faecalis
粪肠球菌第二信使核苷酸
  • 批准号:
    10676471
  • 财政年份:
    2023
  • 资助金额:
    $ 11.78万
  • 项目类别:
Second Messenger Nucleotides of Enterococcus faecalis
粪肠球菌第二信使核苷酸
  • 批准号:
    10672673
  • 财政年份:
    2022
  • 资助金额:
    $ 11.78万
  • 项目类别:
Cyclic di-GMP Second Messenger Signaling in the Tickborne Relapsing Fever Spirochete, Borrelia turicatae
蜱传回归热螺旋体、Borrelia turicatae 中的环状 di-GMP 第二信使信号传导
  • 批准号:
    10378138
  • 财政年份:
    2021
  • 资助金额:
    $ 11.78万
  • 项目类别:
Metabolic control of the second messenger cyclic diguanylate: implications to intracellular bacterial pathogens
第二信使环二鸟苷酸的代谢控制:对细胞内细菌病原体的影响
  • 批准号:
    10055808
  • 财政年份:
    2020
  • 资助金额:
    $ 11.78万
  • 项目类别:
The role of microbial second messenger synthesis in intestinal homeostasis
微生物第二信使合成在肠道稳态中的作用
  • 批准号:
    10348206
  • 财政年份:
    2020
  • 资助金额:
    $ 11.78万
  • 项目类别:
Bacterial Second Messenger Mediated Virulence Regulation in Streptococcus mutans
细菌第二信使介导的变形链球菌毒力调节
  • 批准号:
    10545763
  • 财政年份:
    2020
  • 资助金额:
    $ 11.78万
  • 项目类别:
Generation and application of second messenger molecules by SMODS and SAVED
SMODS和SAVED第二信使分子的生成和应用
  • 批准号:
    9916469
  • 财政年份:
    2020
  • 资助金额:
    $ 11.78万
  • 项目类别:
Bacterial Second Messenger Mediated Virulence Regulation in Streptococcus mutans
细菌第二信使介导的变形链球菌毒力调节
  • 批准号:
    10227894
  • 财政年份:
    2020
  • 资助金额:
    $ 11.78万
  • 项目类别:
Generation and application of second messenger molecules by SMODS and SAVED
SMODS和SAVED第二信使分子的生成和应用
  • 批准号:
    10078261
  • 财政年份:
    2020
  • 资助金额:
    $ 11.78万
  • 项目类别:
Characterization of a novel nucleotide based second messenger system regulating innate immune responses
调节先天免疫反应的新型核苷酸第二信使系统的表征
  • 批准号:
    423400107
  • 财政年份:
    2019
  • 资助金额:
    $ 11.78万
  • 项目类别:
    Research Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了